Sickle Cell and Thalassemia Program

The Comprehensive Sickle Cell and Thalassemia Program is home to over 280 children, adolescents and young adults, with sickle cell anemia and other disorders of hemoglobin including beta thalassemia, emphasizing primary, secondary and tertiary prevention and treatment using a multidisciplinary team approach. Children’s program is recognized as one of six selected clinical centers for the management of children with sickle cell anemia by the Ohio Department of health, and oversees newborn screening, counseling, clinical management of acute complications and long-term follow-up care for the largest region of the state.

US News Badge Cancer

The division of Hematology, Oncology & Blood and Marrow Transplant is ranked in the Top 10 by US News and World Report.


Children’s highly specialized services include state-of-the-art screening and management of cerebrovasular, neurologic, cardiac and hepatobiliary complications. Our experts also provide complete transfusion support services, iron overload management, clinical psychological testing and follow-up, diagnostic testing and counseling and bone marrow transplantation. We are a leader in quality of life research in sickle cell anemia and participate in a variety of federally-funded clinical trials in sickle cell and thalassemia. This physician lead team includes a nurse practitioner, social worker, psychologist, nutritionist, nurse clinician, program coordinator, pastoral care and newborn screening coordinator.

Our Clinic 

The Sickle Cell Disease and Thalassemia Clinic focuses on the needs of children, adolescents and adults who have sickle cell disease, thalassemia and other inherited red blood cell disorders. 

The clinic is staffed by board certified hematologists/oncologists Dr. Anthony VillellaDr. Susan Creary, and Jennifer Young, a Certified Nurse Practitioner. During their clinic visit, the pediatric patient with sickle cell disease is seen by a physician, nurse practitioner, nurse clinician, social worker, psychologist, a dentist, and a genetics counselor. Patients along with their families receive education about these illnesses and are counseled on potential therapies. Physical examinations and screenings are completed during each clinic visit to find early signs of complications from the disease so effective treatment can be implemented. Our program is dedicated to providing the highest quality of care and education in a manner that respects the cultural diversity of the community we serve.  

Clinic Information

Sickle Cell Comprehensive Clinic
Nationwide Children's Hospital
700 Children's Drive
Columbus, Ohio 43205
(614) 722-3250


Nationwide Children's Hospital Medical Professional

Amy L. Dunn

Amy Dunn, MD is the Director of Pediatric Hematology and directs the Hemophilia Treatment Center.

Jeffery Auletta

Jeffery J. Auletta

Jeffery Auletta, MD, is the Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases (HD) Program at Nationwide Children's Hospital.

Clinical Research

Tim Cripe in Research Lab

Cancer Clinical Research

Learn more about clinical research relating to cancer.

Nationwide Children's Hospital Patient Stock Photo

Sickle Cell Anemia Clinical Research

Learn more about clinical research relating to sickle cell anemia.

Female resident working in a research lab

Hematologic Disorders

Hematologic disorders are conditions found in the blood and blood forming organs. This includes blood cell cancers, genetic disorders, anemia, HIV related conditions, sickle cell disease, and complications do to chemotherapy treatment or transfusions.


Nationwide Children's Hospital Patient Photo

Hematology and Oncology Outpatient Clinic

The Hematology and Oncology Outpatient Clinic is designed to be a link between the family, home and the hospital.

Young smiling cancer patient wearing head wrap

Musculoskeletal Oncology Program

Our Musculoskeletal Oncology Program focuses on innovative limb salvage strategies and ways to protect quality of life both now and in the future for our patients.